Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse

Blood. 2000 Aug 15;96(4):1619-20.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Burkitt Lymphoma / genetics*
  • Burkitt Lymphoma / pathology*
  • Humans
  • Neoplasm, Residual / diagnosis
  • Neoplasm, Residual / genetics*
  • Neoplasm, Residual / pathology
  • Polymerase Chain Reaction
  • Predictive Value of Tests
  • Recurrence